Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
This study has been completed.
Study NCT00027963 Information provided by National Cancer Institute (NCI)
First Received: December 7, 2001 Last Updated: August 19, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neurotoxicity
Pain
Additional conditions recognized in this trial
Neurotoxicity Syndromes
Peripheral Nervous System Diseases
More general conditions related to this trial
Disorders of Environmental Origin
Nervous System Diseases
Neuromuscular Diseases
Poisoning
Interventions listed in this trial
gabapentin
quality-of-life assessment
More general drug interventions related to this trial
Analgesics
Anti-Anxiety Agents
Anti-Dyskinesia Agents
Anticonvulsants
Antimanic Agents
Antiparkinson Agents
Calcium Channel Blockers
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sensory System Agents
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
North Central Cancer Treatment Group
National Cancer Institute (NCI)
Back to top of Main Content
